Skip to main content
. 2021 Aug 19;35:49–60. doi: 10.1016/j.jare.2021.08.011

Fig. 3.

Fig. 3

(A) The cellular uptake of the PCO nanovaccines in BMDCs. FITC-OVA was used for nanovaccine preparation and FCM detection. (B) The cytotoxicity of the PCO nanovaccines against BMDCs for 24 h.